The global market for a biomarker is projected to have a CAGR of 14.6% during the forecast period. A biomarker is an objective measure that captures what is happening in a cell or an organism at a given moment. Biomarkers can serve as early warning systems for health. Biomarkers can have molecular, histologic, radiographic, or physiological characteristics. The use of biomarkers in basic and clinical research as well as in clinical practice has become so commonplace that their presence as primary endpoints in clinical trials is now accepted almost without question. The key factors contributing to the growth of the global biomarker market include the high prevalence of chronic diseases, rising adoption of the biomarker for diagnostic applications, high government funding for cancer research and clinical trials, increasing application in drug discovery and development. According to the National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP) report, 6 in 10 adults in America live with at least one chronic disease, and 4 in 10 adults are with two or more. It is estimated that by 2060, the U.S. population aged 65 years and older will more than double, from 46 million today to 98 million. The high prevalence of chronic disease led to the demand for an effective biomarker which, in turn, further drive the market growth. The increase in the number of Contract Research Organizations (CROs) and the low cost of clinical trials in emerging economies are anticipated to further boost the growth of the market.
Free Sample Copy @ https://www.omrglobal.com/request-sample/global-biomarker-market
The global biomarker market is segmented based on type, application, disease, and end-user. On the basis of type, the market is bifurcated into genomic and protein biomarker. The application segment is classified into drug discovery & development, diagnostic, prognostic, predictive and others (risk assessment). Among these, the biomarkers in drug discovery and development are anticipated to grow at significant CAGR during the forecast period. Biomarkers can predict the drug efficacy more quickly than conventional clinical endpoints, also they have the potential to accelerate product development in certain disease areas such as cancer, and cardiac disease. The disease segment is segregated into cancer, cardiac, renal, central nervous system disease and others (NASH). The end-user segment is categorized into hospitals, diagnostic centre and research institute.
A Full Report of Global Biomarker Market is Available at:
https://www.omrglobal.com/industry-reports/global-biomarker-market
Geographically, the global Biomarker market is classified into four major regions including North America (the US and Canada), Europe (UK, Germany, France, Italy, Spain, Russia, and Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia-Pacific), and Rest of the World (Latin America and the Middle East and Africa (MEA)). Among these, Asia-Pacific is the fastest-growing region during the forecast period. The factors contributing to the regional growth include the strong population base, high prevalence of chronic diseases such as cancer and CVDs in countries such as China, Japan, and India. Apart from this, improving biopharmaceutical research centres and rising clinical research in the region.
Global Biomarker Market – Segmentation
By Type
Genomic Biomarker
Protein Biomarker
By Application
Drug Discovery and Development
Diagnostic
Prognostic
Predictive
Others (Risk Assessment)
By Disease
Cancer
Cardiac
Renal
Central Nervous System Disease
Others (Nash)
By End User
Hospitals
Diagnostic Centre
Research Institute
Global Biomarker Market – Segmentation by Region
North America
United States
Canada
Europe
Germany
United Kingdom
France
Spain
Italy
Rest of Europe
Asia-Pacific
China
Japan
India
Rest of Asia-Pacific
Rest of the World
Company Profiles
Abbott Laboratories
ACS Biomarker B.V.
Agilent technologies inc.
Abcodia Ltd.
Adx Neurosciences
Avacta Life Sciences Ltd.
Agendia Inc.
Astellas Pharma Inc.
Angle plc
Almac Group
Alcediag
Banyan Biomarkers Inc.
BCAL Diagnostics
Bioclinica
Biodesix Inc.
Bio-Rad Laboratories Inc.
BiomarkerBay B. V.
Biomark Diagnostics Inc.
BioagilytixLabs LLC
BiogazelleNV
BiofluidicaInc.
Biosims technologies SAS
Cellomatics Biosciences Ltd.
Celerion
Covance Inc.
CrossbetaBioscience B.V.
Cambridge Biomedical Inc.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/global-biomarker-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
(This release has been published on Global Market Post.
Global Market Post is not responsible for any content included in this release.)
